Marketing-authorisation holder · Canada
Ambicare Pharmaceuticals Inc.
8 medicines in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
8 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| AMB-BISACODYL10 mg · Suppository | Bisacodyl | Canada | Marketed | 2024 |
| AMB-BUSPIRONE10 mg · Tablet | Buspirone | Canada | Marketed | 2024 |
| AMB-CYPROTERONE ACETATE / ETHINYL ESTRADIOL2 mg + 0.035 mg · Tablet | Cyproterone, Ethinyl estradiol | Canada | Marketed | 2026 |
| AMB-SOTALOL160 mg · Tablet | Sotalol | Canada | Marketed | 2026 |
| AMB-SOTALOL80 mg · Tablet | Sotalol | Canada | Marketed | 2026 |
| MILEY 210.15 mg + 0.03 mg · Tablet | Desogestrel, Ethinyl estradiol | Canada | Marketed | 2025 |
| MILEY 280.15 mg + 0.03 mg · Tablet | Desogestrel, Ethinyl estradiol | Canada | Marketed | 2025 |
| MYPREF1.5 mg · Tablet | Levonorgestrel | Canada | Authorised |